Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. post operative
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Post Operative Articles & Analysis

92 news found

Studying Flow-Induced Pulmonary Hypertension and Compensatory Lung Growth: Insights from A Novel Murine Model

Studying Flow-Induced Pulmonary Hypertension and Compensatory Lung Growth: Insights from A Novel Murine Model

In the realm of pulmonary research, the search to understand complex lung conditions has led to the development of various animal models. Among these, a new murine model from Tsijis et al stands out for its potential to investigate flow-induced pulmonary hypertension (PH) and compensatory lung growth (CLG). This blog outlines this innovative model, its significance, and the method of ...

BySCIREQ - an emka TECHNOLOGIES Company


Post-treatment care after HIFU ultrasound cosmetic treatment

Post-treatment care after HIFU ultrasound cosmetic treatment

HIFU ultrasound treatment will be followed by regular post-operative maintenance according to individual skin ageing conditions, thus making long-term results more stable. 4. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Prolonged Analgesia From Bupisome And Bupigel Formulations: From Design And Fabrication To Improved Stability

Prolonged Analgesia From Bupisome And Bupigel Formulations: From Design And Fabrication To Improved Stability

Based on data from early animal studies, Probudur has indicated post-operative control for up to 96 hours, which is 24 hours longer than the leading product on the market. ...

ByVirpax Pharmaceuticals


Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Commercial and Pipeline Update Product portfolio Acute Care Hospital: RYANODEX®, vasopressin, Barhemsys®, Byfavo® Oncology: BENDEKA, BELRAPZO, PEMFEXY11, TREAKISYM Japan12 75-person commercial team covers all products excluding BENDEKA and TREAKISYM Company projects growth in earnings while still supporting R&D Cash flow from legacy products expected to continue to ...

ByEagle Pharmaceuticals, Inc.


Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

Resected specimens were imaged with Perimeter S-Series OCT in the operating room prior to routine pathology to allow for post-operative comparisons. ...

ByPerimeter Medical Imaging AI


ITM Executes Option to In-license Targeted Radionuclide Therapy Candidate LuCaFab (ITM-31) for the Treatment of Malignant Brain Tumors

ITM Executes Option to In-license Targeted Radionuclide Therapy Candidate LuCaFab (ITM-31) for the Treatment of Malignant Brain Tumors

“Glioblastoma remains one of the most aggressive and difficult to treat cancers globally and we believe that targeted radiotherapy and particularly ITM-31 can make a significant impact for patients by selectively eliminating tumor remnants post-surgery,” said Steffen Schuster, CEO of ITM. “Based on the promising preclinical data we have seen to date and the ...

ByITM Isotope Technologies Munich SE


BioIntelliSense Acquires AlertWatch Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions

BioIntelliSense Acquires AlertWatch Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions

Over the past decade, AlertWatch has earned 4 FDA 510(k) clearances for its specialized product offerings for the operating room, intensive care unit, and labor and delivery unit. AlertWatch is also monitoring patients in general care wards – and now, in the home. ...

ByBioIntelliSense, Inc.


Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SeValent

Bexson’s lead therapy, BB106, is a low-dose ketamine treatment for post-operative pain management, a $36B global market and leading driver of opioid addiction. ...

ByBexson Biomedical


Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

The compound is also being developed by Enalare for the treatment of post-operative respiratory depression and community drug overdose. Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions and community based health emergencies, announced today that ...

ByEnalare Therapeutics Inc.


Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

"We are excited to expand our partnership with BARDA in the development of rapidly deployable intramuscular formulation of ENA-001 for the emergency treatment of substance-induced respiratory depression," stated Daniel Motto, Chief Operating Officer of Enalare Therapeutics. "We appreciate BARDA's recognition of the need for new innovative treatment options and look forward to ...

ByEnalare Therapeutics Inc.


Classification of Fractional Lasers

Classification of Fractional Lasers

Depressed scars and hypertrophic scars -- post-acne depression scars, various post-traumatic scars. 2. Facial rejuvenation -- wrinkles, pores, photoaging, etc. 3. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit

Bexson’s lead therapy, BB106, is a low-dose ketamine treatment for post-operative pain management, a$36B global market and leading driver of opioid addiction. ...

ByBexson Biomedical


Ondine reports successful US Phase 2 trial data

Ondine reports successful US Phase 2 trial data

SSIs are the leading cause of readmissions to hospital following surgery, and approximately 3% of patients who contract an SSI die as a consequence of these infections.[iii] Post-operative infections occur in up to 300,000 patients per year in the United States and cost the US healthcare system tens of billions of dollars a ...

ByOndine Biomedical Inc


Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS - Negative Pressure Surgical Incision Management System

Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS - Negative Pressure Surgical Incision Management System

The single-use, disposable NPSIMS is easily activated and operates silently during therapy delivery. A patented preassembled dressing provides ease-of-application with exceptional ‘sealing’ capability while providing patient comfort and ergonometric appeal. ...

ByAatru Medical, LLC


Empirical Spine Receives FDA Breakthrough Device Designation for the LimiFlex Device Targeting Degenerative Spondylolisthesis

Empirical Spine Receives FDA Breakthrough Device Designation for the LimiFlex Device Targeting Degenerative Spondylolisthesis

Key potential benefits cited in the BDD application include less invasive and shorter surgery, improved intra- and post-operative outcomes, reduction or elimination of hospitalization length of stay, and improved patient quality of life, including motion-preservation at the affected spinal level. ...

ByEmpirical Spine, Inc.


Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant

Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant

ENA-001 is currently in development for: post-operative respiratory depression, community drug overdose, and Apnea of Prematurity Approval for post-operative respiratory depression expected in 2026 and community drug overdose thereafter ENA-001 works peripherally by inhibiting Big Potassium (BK) ion channels in the carotid ...

ByEnalare Therapeutics Inc.


CO2 Fractional Laser Scar Removal Equipment In Medical Beauty Industry

CO2 Fractional Laser Scar Removal Equipment In Medical Beauty Industry

▶Recently there are new closed acne, new red acne on the face, sensitive and red skin Treatment process Doctor's face consultation (skin test) → determine a personalized plan → cleanse (apply anesthetic) → clean the anesthetic, start laser → post-operative cold compress → apply repair medicine Precautions after treatment There is a ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Ondine completes enrollment for US Phase II nasal photodisinfection trial

Ondine completes enrollment for US Phase II nasal photodisinfection trial

Each patient then receives Ondine’s nasal photodisinfection (investigational product) followed by a post-treatment culture, enabling evaluation of the efficacy of nasal photodisinfection across a wide range of patients and surgery types. ...

ByOndine Biomedical Inc


Caresyntax & Intel Collaborate to Address Surgical Staffing Shortage

Caresyntax & Intel Collaborate to Address Surgical Staffing Shortage

Combining capabilities to develop breakthrough technologies for transforming surgery. Hospitals and Surgery Centers face many challenges in surgery as they work to recover from COVID. Directors of Perioperative Services, Surgeons, OR Staff and OR managers are facing high levels of stress with maintaining quality patient care, increasing surgical case volume from backlogs, while at the same time ...

ByCaresyntax


Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

This could reduce the risk of intraoperative and post-operative complications, which would benefit both patients and operators,” said Professor Yundai Chen, director of the cardiology department at the No. 301 Hospital. “The simple and intuitive design of R-One is very convenient for doctors to operate with. We can ...

ByRobocath

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT